MEF2A
Myocyte-specific enhancer factor 2A
Also known as: MEF2A_HUMAN, RSRFC4, RSRFC9
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02078
- Gene
- MEF2A
- Ensembl
- ENSG00000068305
- Chromosome
- 15
- Canonical length
- 507 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
Canonical amino-acid sequenceUniProt
507 residues, UniProt reviewed canonical sequence.
>Q02078|MEF2A
1 MGRKKIQITR IMDERNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNS SNKLFQYAST
61 DMDKVLLKYT EYNEPHESRT NSDIVEALNK KEHRGCDSPD PDTSYVLTPH TEEKYKKINE
121 EFDNMMRNHK IAPGLPPQNF SMSVTVPVTS PNALSYTNPG SSLVSPSLAA SSTLTDSSML
181 SPPQTTLHRN VSPGAPQRPP STGNAGGMLS TTDLTVPNGA GSSPVGNGFV NSRASPNLIG
241 ATGANSLGKV MPTKSPPPPG GGNLGMNSRK PDLRVVIPPS SKGMMPPLSE EEELELNTQR
301 ISSSQATQPL ATPVVSVTTP SLPPQGLVYS AMPTAYNTDY SLTSADLSAL QGFNSPGMLS
361 LGQVSAWQQH HLGQAALSSL VAGGQLSQGS NLSINTNQNI SIKSEPISPP RDRMTPSGFQ
421 QQQQQQQQQQ PPPPPQPQPQ PPQPQPRQEM GRSPVDSLSS SSSSYDGSDR EDPRGDFHSP
481 IVLGRPPNTE DRESPSVKRM RMDAWVTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MEF2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 88 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 88 nTPM
- tongue: 79 nTPM
- skeletal muscle: 58 nTPM
- skin: 52 nTPM
- blood vessel: 48 nTPM
- cerebral cortex: 41 nTPM
Single-cell type
- microglia: 3,037 nCPM
- neutrophils: 1,664 nCPM
- myonuclei: 925 nCPM
- endometrial luminal cells: 873 nCPM
- macrophages: 824 nCPM
- neutrophil progenitors: 671 nCPM
Immune cell
- non-classical monocyte: 23 nTPM
- memory B-cell: 18 nTPM
- intermediate monocyte: 17 nTPM
- eosinophil: 16 nTPM
- myeloid DC: 14 nTPM
- classical monocyte: 13 nTPM
Brain region
- thalamus: 84 nTPM
- cerebral cortex: 81 nTPM
- white matter: 80 nTPM
- midbrain: 69 nTPM
- spinal cord: 65 nTPM
- amygdala: 64 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MEF2A.
Disease | AllUniProt
Conditions MEF2A is implicated in, by any mechanism.
- Coronary artery disease, autosomal dominant, 1 (ADCAD1) MIM:608320
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 76 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Coronary artery disease, autosomal dominant, 1
- Coronary artery disease/myocardial infarction
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.54
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cardiac conduction
- cell differentiation
- cellular response to calcium ion
- dendrite morphogenesis
- DNA-templated transcription
- heart development
- mitochondrion distribution
- muscle cell development
- muscle organ development
- negative regulation of transcription by RNA polymerase II
- positive regulation of cardiac muscle hypertrophy
- positive regulation of D-glucose import
- positive regulation of gene expression
- positive regulation of transcription by RNA polymerase II
- ventricular cardiac myofibril assembly
Molecular functions
- chromatin binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- histone acetyltransferase binding
- histone deacetylase binding
- protein heterodimerization activity
- protein kinase binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific DNA binding
- SMAD binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MEF2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MEF2A as an antibody target. Whether an autoantibody or antibody against MEF2A could matter depends on whether native MEF2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MEF2A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MEF2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...